Name: BARINTHUS BIOTHERAPEUTICS PL (BRNS) Stock
Brand: BARINTHUS BIOTHERAPEUTICS PL
Rating: 4 (3 reviews)

BRNS Latest News, Press Relases and Analysis

All

Press Releases

15 days ago - By: Chartmill - Mentions: FMFC IRWD SGRY COGT ...

Top movers in Monday's session

5 days ago - By: Halper Sadeh LLC - Mentions: HFWA FITB

Halper Sadeh LLC Encourages HFWA, BRNS, FITB Shareholders to Contact the Firm to Discuss Their Rights

7 days ago - By: Halper Sadeh LLC - Mentions: HFWA FITB AVDL

Halper Sadeh LLC Encourages HFWA, FITB, AVDL, BRNS Shareholders to Contact the Firm to Discuss Their Rights

15 days ago - By: Benzinga - Mentions: COGT IRWD PBYI AKBA ...

12 Health Care Stocks Moving In Monday's Intraday Session

18 days ago - By: Barinthus Biotherapeutics

Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments

18 days ago - By: Barinthus Biotherapeutics

Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments

a month ago - By: ChemDiv

ChemDiv Continues R&D Services Support for Clywedog Therapeutics Following Merger with Barinthus Therapeutics

a month ago - By: Brodsky & Smith LLC - Mentions: ETNB VRNT DAY

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)

2 months ago - By: Halper Sadeh LLC - Mentions: DAY ETNB VRNT

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates DAY, BRNS, ETNB, VRNT on Behalf of Shareholders

2 months ago - By: Brodsky & Smith LLC - Mentions: ETNB VRNT DAY

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)

2 months ago - By: Benzinga - Mentions: RFL OMI XTLB ESPR ...

12 Health Care Stocks Moving In Tuesday's After-Market Session

2 months ago - By: Halper Sadeh LLC - Mentions: VECO VRNT

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VECO, BRNS, VRNT on Behalf of Shareholders

2 months ago - By: Kahn Swick & Foti, LLC

BARINTHUS BIOTHERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Barinthus Biotherapeutics plc - BRNS

2 months ago - By: Halper Sadeh LLC

BRNS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Barinthus Biotherapeutics plc Is Fair to Shareholders

2 months ago - By: Stocktwits

Barinthus Biotherapeutics To Merge With Privately-Held Clywedog Therapeutics

2 months ago - By: Barinthus Biotherapeutics

Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases

2 months ago - By: Barinthus Biotherapeutics

Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases

4 months ago - By: Barinthus Biotherapeutics

Barinthus Bio Reports Second Quarter 2025 Financial Results and Updates on Corporate Developments

4 months ago - By: Barinthus Biotherapeutics

Barinthus Bio Reports Second Quarter 2025 Financial Results and Updates on Corporate Developments

5 months ago - By: ACCESS Newswire - Mentions: MNRG.CA OPHC XHLD ROLR ...

Q2 Virtual Investor Summit: Presentations Available Now

6 months ago - By: ACCESS Newswire

Barinthus Biotherapeutics' CEO Bill Enright to Present at the Investor Summit Virtual on June 10, 2025

7 months ago - By: Barinthus Biotherapeutics

Barinthus Bio Reports First Quarter 2025 Financial Results and Updates on Corporate Developments

7 months ago - By: Barinthus Biotherapeutics

Barinthus Bio Reports First Quarter 2025 Financial Results and Updates on Corporate Developments

8 months ago - By: Barinthus Biotherapeutics

Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments

8 months ago - By: Barinthus Biotherapeutics

Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments

8 months ago - By: ACCESS Newswire - Mentions: DRTS GIFT VOXR FEMY ...

Q1 Virtual Investor Summit: On-Demand Presentations Now Live

9 months ago - By: ACCESS Newswire

Barinthus Biotherapeutics plc to Present at the Investor Summit Virtual on March 11

11 months ago - By: Barinthus Biotherapeutics

BARINTHUS BIOTHERAPEUTICS PL (BRNS) Stock News

BRNS Latest News, Press Relases and Analysis

Top movers in Monday's session

Halper Sadeh LLC Encourages HFWA, BRNS, FITB Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC Encourages HFWA, FITB, AVDL, BRNS Shareholders to Contact the Firm to Discuss Their Rights

12 Health Care Stocks Moving In Monday's Intraday Session

Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments

Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments

ChemDiv Continues R&D Services Support for Clywedog Therapeutics Following Merger with Barinthus Therapeutics

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates DAY, BRNS, ETNB, VRNT on Behalf of Shareholders

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), Dayforce, Inc. (NYSE- DAY)

12 Health Care Stocks Moving In Tuesday's After-Market Session

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VECO, BRNS, VRNT on Behalf of Shareholders

BARINTHUS BIOTHERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Barinthus Biotherapeutics plc - BRNS

BRNS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Barinthus Biotherapeutics plc Is Fair to Shareholders

Barinthus Biotherapeutics To Merge With Privately-Held Clywedog Therapeutics

Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases

Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases

Barinthus Bio Reports Second Quarter 2025 Financial Results and Updates on Corporate Developments

Barinthus Bio Reports Second Quarter 2025 Financial Results and Updates on Corporate Developments

Q2 Virtual Investor Summit: Presentations Available Now

Barinthus Biotherapeutics' CEO Bill Enright to Present at the Investor Summit Virtual on June 10, 2025

Barinthus Bio Reports First Quarter 2025 Financial Results and Updates on Corporate Developments

Barinthus Bio Reports First Quarter 2025 Financial Results and Updates on Corporate Developments

Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments

Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments

Q1 Virtual Investor Summit: On-Demand Presentations Now Live

Barinthus Biotherapeutics plc to Present at the Investor Summit Virtual on March 11

Barinthus Bio Announces Strategic Focus in Immunology and Inflammation (I&I) and Provides a Financial Update